Andrew E. Budson, MD

Professor, Neurology

Andrew Budson
857.364.6184
150 S Huntington Avenue

Biography

Andrew E. Budson, M.D. is Chief of Cognitive & Behavioral Neurology, Associate Chief of Staff for Education, and Director of the Center for Translational Cognitive Neuroscience at the Veterans Affairs (VA) Boston Healthcare System, Associate Director and Outreach, Recruitment, and Engagement (ORE) Core Leader at the Boston University Alzheimer’s Disease Research Center, Professor of Neurology at Chobanian and Avedisian School of Medicine, and Lecturer in Neurology at Harvard Medical School. His training included graduating cum laude from Harvard Medical School, being chief resident of the Harvard-Longwood Neurology Residency Program, pursuing a fellowship in dementia at Brigham and Women’s Hospital, and studying memory as a post-doctoral fellow in experimental psychology and cognitive neuroscience at Harvard University. Dr. Budson has had government research funding since 1998, receiving a National Research Service Award and a Career Development Award in addition to a Research Project (R01) grant. He has given over 800 local, national, and international grand rounds and other academic talks. He has published over 150 papers, reviews, and book chapters and is a reviewer for more than 50 journals. He has co-authored or edited eight books, including Memory Loss, Alzheimer’s Disease, and Dementia: A Practical Guide for Clinicians (translated into Spanish, Portuguese, and Japanese), Seven Steps to Managing Your Memory (translated into Korean and Simplified Chinese), Six Steps to Managing Alzheimer’s Disease and Dementia: A Guide for Families, and Why We Forget and How to Remember Better: The Science Behind Memory. He was awarded the Norman Geschwind Prize in Behavioral Neurology in 2008 and the Research Award in Geriatric Neurology in 2009, both from the American Academy of Neurology. His current research uses the techniques of experimental psychology and cognitive neuroscience to understand memory in patients with Alzheimer’s disease. In his memory disorders clinic at the VA Boston Healthcare System he treats patients while teaching fellows, residents, and medical students.

Other Positions

  • Associate Director for Research, Alzheimer's Disease Center, Boston University Chobanian & Avedisian School of Medicine
  • Professor, Pathology & Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine
  • Consultant Neurologist, Division of Cognitive & Behavioral Neurology, Neurology, Brigham and Women's Hospital
  • Associate Chief of Staff for Education, VA Boston Healthcare System
  • Director, Center for Translational Cognitive Neuroscience, VA Boston Healthcare System
  • Director, Cognitive Neuroscience Research, Alzheimer’s Disease Center, Boston University Chobanian & Avedisian School of Medicine
  • Lecturer in Neurology, Neurology, Harvard Medical School
  • Physician, Geriatric Research Education Clinical Center & Neurology Services, VA Boston Healthcare System
  • VA Boston Healthcare System
  • Graduate Faculty (Primary Mentor of Grad Students), Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences

Education

  • Harvard Medical School, MD
  • Harverford College, BA

Publications

  • Published on 12/30/2023

    Montoliu-Gaya L, Alosco ML, Yhang E, Tripodis Y, Sconzo D, Ally M, Grötschel L, Ashton NJ, Lantero-Rodriguez J, Sauer M, Gomes B, Nilsson J, Brinkmalm G, Sugarman MA, Aparicio HJ, Martin B, Palmisano JN, Steinberg EG, Simkin I, Turk KW, Budson AE, Au R, Farrer L, Jun GR, Kowall NW, Stern RA, Goldstein LE, Qiu WQ, Mez J, Huber BR, Alvarez VE, McKee AC, Zetterberg H, Gobom J, Stein TD, Blennow K. Optimal blood tau species for the detection of Alzheimer's disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study. Acta Neuropathol. 2023 Dec 30; 147(1):5. PMID: 38159140.

    Read at: PubMed
  • Published on 11/27/2023

    Groechel RC, Alosco ML, Dixon D, Tripodis Y, Mez J, Goldstein L, Budson AE, Qiu WQ, Killiany RJ. Associations between white matter integrity of the cingulum bundle, surrounding gray matter regions, and cognition across the dementia continuum. J Comp Neurol. 2023 Dec; 531(18):2162-2171. PMID: 38010204.

    Read at: PubMed
  • Published on 10/25/2023

    Ally M, Sugarman MA, Zetterberg H, Blennow K, Ashton NJ, Karikari TK, Aparicio HJ, Frank B, Tripodis Y, Martin B, Palmisano JN, Steinberg EG, Simkin I, Farrer LA, Jun GR, Turk KW, Budson AE, O'Connor MK, Au R, Goldstein LE, Kowall NW, Killiany R, Stern RA, Stein TD, McKee AC, Qiu WQ, Mez J, Alosco ML. Cross-sectional and longitudinal evaluation of plasma glial fibrillary acidic protein to detect and predict clinical syndromes of Alzheimer's disease. Alzheimers Dement (Amst). 2023; 15(4):e12492. PMID: 37885919.

    Read at: PubMed
  • Published on 10/10/2023

    Marin A, Budson AE. Recent advances in understanding Alzheimer's Disease: diagnosis and management strategies. Fac Rev. 2023; 12:24. PMID: 37829574.

    Read at: PubMed
  • Published on 9/1/2023

    Farrar DC, Killiany RJ, Moss MB, Fink B, Budson AE. Event-related Potentials Corresponding to Decision-making Under Uncertain Conditions. Cogn Behav Neurol. 2023 Sep 01; 36(3):166-177. PMID: 37404132.

    Read at: PubMed
  • Published on 7/20/2023

    Groechel RC, Tripodis Y, Alosco ML, Mez J, Qiao Qiu W, Goldstein L, Budson AE, Kowall NW, Shaw LM, Weiner M, Jack CR, Killiany RJ. Biomarkers of Alzheimer's disease in Black and/or African American Alzheimer's Disease Neuroimaging Initiative (ADNI) participants. Neurobiol Aging. 2023 Nov; 131:144-152. PMID: 37639768.

    Read at: PubMed
  • Published on 6/12/2023

    Friedman G, Turk KW, Budson AE. The Current of Consciousness: Neural Correlates and Clinical Aspects. Curr Neurol Neurosci Rep. 2023 Jul; 23(7):345-352. PMID: 37303019.

    Read at: PubMed
  • Published on 3/10/2023

    Groechel RC, Tripodis Y, Alosco ML, Mez J, Qiu WQ, Mercier G, Goldstein L, Budson AE, Kowall NW, Killiany RJ. Annualized changes in rate of amyloid deposition and neurodegeneration are greater in participants who become amyloid positive than those who remain amyloid negative. Neurobiol Aging. 2023 Jul; 127:33-42. PMID: 37043881.

    Read at: PubMed
  • Published on 12/1/2022

    Budson AE, Richman KA, Kensinger EA. Consciousness as a Memory System. Cogn Behav Neurol. 2022 Dec 01; 35(4):263-297. PMID: 36178498.

    Read at: PubMed
  • Published on 10/21/2022

    Morrison MS, Aparicio HJ, Blennow K, Zetterberg H, Ashton NJ, Karikari TK, Tripodis Y, Martin B, Palmisano JN, Sugarman MA, Frank B, Steinberg EG, Turk KW, Budson AE, Au R, Goldstein LE, Jun GR, Kowall NW, Killiany R, Qiu WQ, Stern RA, Mez J, McKee AC, Stein TD, Alosco ML. Ante-mortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsy. Brain. 2022 Oct 21; 145(10):3546-3557. PMID: 35554506.

    Read at: PubMed

View 146 more publications: View full profile at BUMC

View all profiles